These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 17662773)
21. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots. Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315 [TBL] [Abstract][Full Text] [Related]
22. A practical approach for bridging anticoagulation after mechanical heart valve replacement. Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932 [TBL] [Abstract][Full Text] [Related]
23. A combination of a thrombin inhibitor and dexamethasone prevents the development of experimental disseminated intravascular coagulation in rats. Elg M; Gustafsson D Thromb Res; 2006; 117(4):429-37. PubMed ID: 15869787 [TBL] [Abstract][Full Text] [Related]
25. Thrombin inhibition with melagatran does not attenuate renal ischaemia-reperfusion injury in rats. Nitescu N; Grimberg E; Ricksten SE; Marcussen N; Guron G Nephrol Dial Transplant; 2007 Aug; 22(8):2149-55. PubMed ID: 17405786 [TBL] [Abstract][Full Text] [Related]
26. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury. Wang CX; Ding X; Shuaib A Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697 [TBL] [Abstract][Full Text] [Related]
27. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702 [TBL] [Abstract][Full Text] [Related]
28. Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination. Koestenberger M; Gallistl S; Cvirn G; Baier K; Leschnik B; Muntean W Thromb Res; 2005; 115(1-2):135-42. PubMed ID: 15567465 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience of melagatran/ximelagatran in major orthopaedic surgery. Eriksson BI Thromb Res; 2003 Jul; 109 Suppl 1():S23-9. PubMed ID: 12818631 [TBL] [Abstract][Full Text] [Related]
30. The direct thrombin inhibitor melagatran counteracts endotoxin-induced endothelial leukocyte adherence and microvascular leakage in the rat mesentery. Rationale for the treatment of inflammatory disorders beyond sepsis? Leithäuser B; Fassbender M; Eickhoff M; Elg M; Eichner G; Matthias FR Clin Hemorheol Microcirc; 2007; 36(4):277-89. PubMed ID: 17502698 [TBL] [Abstract][Full Text] [Related]
31. Early anticoagulation after mechanical valve implantation, and related complications. Puri D; Kumar A; Basu R; Chaudhary A; Sarwal V; Sahoo M; Mahant TS J Heart Valve Dis; 2008 Jul; 17(4):418-24; discussion 425. PubMed ID: 18751472 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers. Dorani H; Schützer KM; Sarich TC; Wall U; Logren U; Ohlsson L; Eriksson UG Eur J Clin Pharmacol; 2007 Jun; 63(6):571-81. PubMed ID: 17387462 [TBL] [Abstract][Full Text] [Related]
33. Ximelagatran: pharmacokinetics and pharmacodynamics of a new strategy for oral direct thrombin inhibition. Kereiakes DJ Rev Cardiovasc Med; 2004; 5 Suppl 5():S4-11. PubMed ID: 15619615 [TBL] [Abstract][Full Text] [Related]
34. Three vehicle formulations for melagatran, a direct thrombin inhibitor, evaluated in a vena cava thrombosis model in the rat. Elg M; Börjesson I; Carlsson S Biopharm Drug Dispos; 2003 Sep; 24(6):251-7. PubMed ID: 12973822 [TBL] [Abstract][Full Text] [Related]
35. Effects of melagatran on activated partial thromboplastin time and on ecarin clotting time in cord versus adult plasma. Koestenberger M; Gallistl S; Bettina L; Cimenti C; Kutschera J; Cvirn G Blood Coagul Fibrinolysis; 2006 Nov; 17(8):677-80. PubMed ID: 17102656 [TBL] [Abstract][Full Text] [Related]
37. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. Stassano P; Di Tommaso L; Monaco M; Iorio F; Pepino P; Spampinato N; Vosa C J Am Coll Cardiol; 2009 Nov; 54(20):1862-8. PubMed ID: 19892237 [TBL] [Abstract][Full Text] [Related]